Tag: recommends

Categories
Health

HHS secretary recommends states open pictures to older People, weak teams

HHS secretary recommends states open shots to older Americans, vulnerable groups

Minister of Health and Human Services Alex Azar on Wednesday urged states not to micromanage their assigned coronavirus vaccine doses, saying it was better to get the shots off as soon as possible, even if they don’t all have theirs Vaccinate healthcare workers.

“There is no reason states need to complete vaccination of all health care providers before opening vaccinations to older Americans or other high-risk populations,” Azar told reporters during a news conference.

“When they use all of the vaccine that’s allocated, ordered, distributed, shipped, and got it in the arms of the healthcare providers, that’s all great,” he added. “But if for some reason their distribution is difficult and you have vaccines in freezers, then you should definitely open them to people 70 and over.”

US officials are trying to speed up the pace of vaccinations after a slower-than-expected initial rollout. The coronavirus pandemic in the United States continues to grow. The nation has at least 219,200 new Covid-19 cases and at least 2,670 virus-related deaths each day, based on a seven-day average calculated by CNBC using data from Johns Hopkins University.

The Centers for Disease Control and Prevention has provided states with an overview recommending that priority be given to health workers and nursing homes first. However, states may distribute the vaccine at their own discretion.

Azar said Wednesday that states that offer some “flexibility” about who gets the first doses are “the best way to get more shots in the arms, faster”. “Faster administration could save lives now, which means we cannot allow perfect to be the enemy of good,” he said. “Hope is here in the form of vaccines.”

More than 4.8 million people in the United States received their first dose of a coronavirus vaccine at 9 a.m. ET on Tuesday, according to the CDC. The number is a far cry from the federal government’s goal of vaccinating 20 million Americans by the end of 2020 and 50 million Americans by the end of this month.

US officials admitted vaccine distribution was slower than hoped. Dr. Nancy Messonnier, director of the CDC’s National Center for Immunization and Respiratory Diseases, told STAT News Tuesday that she expects the vaccine rollout to accelerate “fairly massively” in the coming weeks.

“It is the beginning of a really complicated task, but one that we are ready for,” she told STAT.

Global health experts had said distributing the vaccines to around 331 million Americans within a few months could prove to be much more complicated and chaotic than originally thought. In addition to making adequate doses, states and territories also need enough needles, syringes, and bottles to complete vaccinations.

The logistics involved in obtaining and administering the vaccine are complex and require special training. For example, Pfizer’s vaccine requires a storage temperature of minus 94 degrees Fahrenheit. Pfizer and Moderna vaccines cannot be re-frozen and must be given at room temperature and within hours, otherwise there is a risk of going bad.

Read More: The Long Road Of The Covid Vaccine: How Doses Get From The Manufacturing Plant To Your Arm

Azar also said the holidays likely played a factor in the slow adoption of vaccines. Healthcare providers knew it would be difficult to hire millions of people for vaccinations by December.

Nearly 20 million doses of vaccine have been dispensed to more than 13,000 locations across the country, General Gustave Perna, who oversees logistics for President Donald Trump’s Operation Warp Speed ​​vaccination program, said during the same meeting.

The vaccine distribution is going “very well,” he said, adding that officials are still working to improve the process. “Our goal is to keep the drum beat constant so that states have a cadence of allocation planning and then the appropriate allocation to the right places as indicated.”

“We are constantly re-evaluating the numbers and making sure that they are distributed in the right places [and] Make sure execution is happening so other decisions can be made about assignments, “he added.

Categories
Health

C.D.C. Panel Recommends Pfizer Vaccine for Sufferers as Younger as 16

C.D.C. Panel Recommends Pfizer Vaccine for Patients as Young as 16

An independent panel of experts advising the Centers for Disease Control and Prevention on Saturday afternoon voted to recommend the Pfizer coronavirus vaccine for people aged 16 and over. This confirmation, which only Dr. Robert Redfield, the director of the CDC, is an important signal for hospitals and doctors to continue vaccinating patients.

The confirmation follows the approval of the emergency vaccine on Friday night by the Food and Drug Administration, which oversees the licensing of medical devices.

The advisory board, which typically meets three times a year to review changes to routine vaccine schedules for children, adolescents, and adults, held numerous marathon sessions this fall to resolve a variety of gnarled questions related to the introduction of the novel vaccine to discuss, which is limited in availability during a pandemic.

In the Friday and Saturday sessions, the panel’s heated discussions focused on three main areas: whether the vaccine should be recommended for patients aged 16 and 17, for pregnant and breastfeeding women, and for patients with an anaphylactic reaction to other vaccines .

CDC officials and scientists will review the debate and provide more detailed guidance on these and other groups on Sunday and in the coming weeks as more information about the vaccine becomes available.

Shipments of nearly three million doses of the vaccine will go to the States this weekend. Most states are expected to follow CDC guidelines to reserve these doses for caregivers and residents of nursing homes and long-term care facilities.

Pregnant women were not included in clinical trials with the vaccine. The panel’s discussion on pregnancy centered on the fact that at least 330,000 health care workers in the first cohort of vaccine recipients are expected to be pregnant or breastfeeding women. While the committee urged that the decision on whether to fire the shot be left to pregnant women in consultation with their doctors, it also suggested that they object to the vaccine’s effectiveness and their personal risk of exposure to the virus the lack of data on weighing it up in relation to pregnancy.

The committee found it was not a live virus vaccine and therefore posed no risk to a nursing child.

Pfizer officials said Friday they had seen no evidence that the vaccine affects pregnancy or fertility. About two dozen women became pregnant during post-vaccination clinical trials, and the company is monitoring them.

Committee members responded to warning signs and instructions on anaphylaxis after two UK health workers had severe allergic reactions immediately after being vaccinated. Members tried to strike a balance: taking reasonable precautions without alarming a public who may already be upset about the vaccine. On Saturday, they tended to advise patients with “severe allergic reactions” like anaphylaxis to any component of the vaccine not to get the shot. They also recommended monitoring patients for 15 minutes immediately after vaccination and 30 minutes for patients with a history of anaphylaxis.

The road to a coronavirus vaccine ›

Answers to your vaccine questions

With a coronavirus vaccine spreading out of the US, here are answers to some questions you may be wondering about:

    • If I live in the US, when can I get the vaccine? While the exact order of vaccine recipients may vary from state to state, most doctors and residents of long-term care facilities will come first. If you want to understand how this decision is made, this article will help.
    • When can I get back to normal life after the vaccination? Life will only get back to normal once society as a whole receives adequate protection against the coronavirus. Once countries have approved a vaccine, they can only vaccinate a few percent of their citizens in the first few months. The unvaccinated majority remain susceptible to infection. A growing number of coronavirus vaccines show robust protection against disease. However, it is also possible that people spread the virus without knowing they are infected because they have mild symptoms or no symptoms at all. Scientists don’t yet know whether the vaccines will also block the transmission of the coronavirus. Even vaccinated people have to wear masks for the time being, avoid the crowds indoors and so on. Once enough people are vaccinated, it becomes very difficult for the coronavirus to find people at risk to become infected. Depending on how quickly we as a society achieve this goal, life could approach a normal state in autumn 2021.
    • Do I still have to wear a mask after the vaccination? Yeah, but not forever. The two vaccines that may be approved this month clearly protect people from contracting Covid-19. However, the clinical trials that produced these results were not designed to determine whether vaccinated people could still spread the coronavirus without developing symptoms. That remains a possibility. We know that people who are naturally infected with the coronavirus can spread it without experiencing a cough or other symptoms. Researchers will study this question intensively when the vaccines are introduced. In the meantime, self-vaccinated people need to think of themselves as potential spreaders.
    • Will it hurt What are the side effects? The vaccine against Pfizer and BioNTech, like other typical vaccines, is delivered as a shot in the arm. The injection is no different from the ones you received before. Tens of thousands of people have already received the vaccines, and none of them have reported serious health problems. However, some of them have experienced short-lived symptoms, including pain and flu-like symptoms that usually last a day. It is possible that people will have to plan to take a day off or go to school after the second shot. While these experiences are not pleasant, they are a good sign: they are the result of your own immune system’s encounter with the vaccine and a strong response that ensures lasting immunity.
    • Will mRNA vaccines change my genes? No. Moderna and Pfizer vaccines use a genetic molecule to boost the immune system. This molecule, known as mRNA, is eventually destroyed by the body. The mRNA is packaged in an oily bubble that can fuse with a cell, allowing the molecule to slide inside. The cell uses the mRNA to make proteins from the coronavirus that can stimulate the immune system. At any given moment, each of our cells can contain hundreds of thousands of mRNA molecules that they produce to make their own proteins. As soon as these proteins are made, our cells use special enzymes to break down the mRNA. The mRNA molecules that our cells make can only survive a few minutes. The mRNA in vaccines is engineered to withstand the cell’s enzymes a little longer, so the cells can make extra viral proteins and trigger a stronger immune response. However, the mRNA can hold for a few days at most before it is destroyed.

When asked whether the vaccine should be approved for 16- and 17-year-olds, several paediatricians on the committee expressed concern that Pfizer’s data to date on the youngest participants was “thin”.

However, other committee members pushed back, saying the physiological difference between a 16-year-old and an 18-year-old was minimal. People under the age of 18 who work in long-term care facilities and “important” jobs like groceries are at high risk of contracting the virus and would likely be recommended for initial admissions, they said.

Doctors determined that these teenagers may be disproportionately colored people. By disfellowshipping them, the doctors argued, the committee would inadvertently discriminate against them based on their age.

And, as they added, because the data on side effects and efficacy are so positive, the risk of teenagers getting the virus – as well as spreading it and disrupting their schooling – outweighed the known risks of the vaccine itself.

The committee also expressed its support for making the vaccine available to people who previously tested positive for the virus. Given the limited supplies, they asked those infected within 90 days to wait until that period had expired.

The CDC is expected to issue more detailed clinical recommendations on Sunday. In addition, a comprehensive “toolkit” for providers and patients has been published that is intended to provide detailed information on how to resolve potential concerns.

Categories
Business

CDC panel recommends Pfizer Covid vaccine for folks 16 years and older, clearing pivotal hurdle

CDC panel recommends Pfizer Covid vaccine for people 16 years and older, clearing pivotal hurdle

CDC headquarters in Atlanta

Elijah Nouvelage | Bloomberg via Getty Images

A key panel from the U.S. Centers for Disease Control and Prevention unanimously voted on Saturday to recommend Pfizer-BioNTech’s Covid-19 vaccine for people aged 16 and over. This cleared another crucial hurdle for the drug before the vaccinations begin in the coming days.

The CDC’s Advisory Committee on Immunization Practices, an external group of medical experts advising the agency, voted 11-0 in favor of recommending the vaccine for use in people aged 16 and over under the Food and Drug Administration’s emergency clearance. Three members withdrew due to conflicts.

The recommendation will now be sent to CDC Director Dr. Robert Redfield who must sign out before vaccinations can begin. A CDC spokesman was not immediately available for comment on when Redfield would sign the recommendation.

“This Covid-19 vaccine gives us hope,” said Veronica McNally, ACIP member and assistant dean of experiential education at Michigan State University College of Law. “It’s important to remember that while this vaccine was being developed at an incredible pace and incorporating new technologies, it went through all appropriate channels of regulation and the approval process was transparent.”

Dr. Beth Bell, an ACIP member and clinical professor of global health at the University of Washington, said she recognized people’s concern about this vaccine and new vaccines in general, but added that they were “safely” taking this vaccine when it is she will turn.

“I believe the process we have used here at ACIP to make this decision is transparent, science-based, fair-minded, and for this moment the absolute best we can do,” said Bell .

The vote marked the end of an hour-long meeting during which ACIP members heard presentations from CDC officials on clinical considerations for those vaccinated under the emergency license.

Dr. Sarah Mbaeyi, a CDC doctor, told the agency during a presentation that vaccines should be offered to people “regardless of a history of previous symptomatic or asymptomatic” coronavirus infection. However, Mbaeyi told the panel that a diagnostic or antibody test is not recommended to help decide whether someone should receive the vaccine.

More studies on the vaccine’s safety in pregnant women are ongoing, Mbaeyi said. However, if a pregnant woman is part of a group that is prioritized for the vaccine, Mbaeyi said she could opt for vaccination after making an informed decision with a health care provider.

The public was also asked to share comments and concerns about the vaccine and its dissemination. Claire Hannan, the executive director of the Association of Immunization Managers, told the committee that there needs to be more precise guidance on who is considered an essential worker, as definitions differ across the US.

On December 1, the group voted 13-1 for healthcare workers and residents of long-term care facilities to receive the first doses of vaccine once released for public use. The ACIP emergency meeting, postponed from Sunday to Saturday, followed the FDA’s decision to give Pfizer’s vaccine emergency approval on Friday evening.